| Bioactivity | EAPB 02303 is a microtubule-disrupting agent and inhibitor. EAPB 02303 induces mitosis arrest and impairment of spindle assembly. Thus, EAPB 02303 induces apoptosis and exhibits antitumor activity. EAPB 02303 also exhibits a potent synergy with Paclitaxel (HY-B0015) at lower concentrations[1]. |
| Name | EAPB 02303 |
| CAS | 1958290-51-1 |
| Formula | C17H14N4O2 |
| Molar Mass | 306.32 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Bigot K, et al. Imiqualines for pancreatic cancer: first-in-class potent and synergistic inhibitors of microtubule polymerisation[J]. Cancer Research, 2023, 83(7_Supplement): 5729-5729. |
EAPB 02303
CAS: 1958290-51-1 F: C17H14N4O2 W: 306.32
EAPB 02303 is a microtubule-disrupting agent and inhibitor. EAPB 02303 induces mitosis arrest and impairment of spindle
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.